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Field And Laboratory Screening For Fluvalinate Resistant 
Varroa Populations In Portugal
Introduction
The varroa mite (Varroa destructor) was
first detected in Portugal in 1986. Since
then, there has been a widespread use of
what were the only two registered
treatments Apistan (fluvalinate) and
Apivar (amitraz). Following (i) the
practically exclusive dependence of these
two pyrethroids to cope with varroa and
(ii) repeated claims from national
beekeepers of poor efficacy of Apistan
treatments, a large screening project was
established in 2003 for trying to identify
varroa populations tolerant to fluvalinate
in Portuguese honey bee colonies.
Materials and methods
Results
Conclusions
Approximately 1% of continental country-
colonies were field-tested according to the
“British National Bee Unit” field-testing
methodology, and compared to blank
control tests (same kits and methodology,
but without using fluvalinate). Brood
samples were later collected for laboratory
(Milani, 1995) reassessment of
populations of varroa that had been
flagged, by the field tests, as resistant to
fluvalinate.
From those investigated colonies, approximately
38% (1536) allowed conclusive testing (i.e. where 3
or more varroa per honey bee colony were
submitted to the action of fluvalinate).
Approximately 57 % (878) of these colonies were
considered to host varroa populations highly
tolerant to fluvalinate (using, as border line, 60 %
of fluvalinate induced varroa mortality).
Field tests of colonies where highly fluvalinate-
tolerant varroa populations were found studied an
average of 18 mites and showed an average
therapeutic efficacy of fluvalinate of 26.4 %
(s.e.m. of 0.6 %).
Laboratory data for brood samples was relatively
limited (approximately, 56% of brood samples
were rejected, due the small number of mites on
them).
In most cases (44%), we could lab-confirm the
results provided by the field tests, regarding the
indications provided in terms of varroa status to
fluvalinate tolerance.
Field and lab testing for fluvalinate-
tolerance varroa status provide
convergent results, with the later
frequently confirming the indications
provided by field testing.
Fig 1. Loaded “British National 
Bee Unit” field-test kit
Fig. 2.  Dead varroa after Apistan treatment (2,5% of  
fluvalinate) 
Fig. 3.  Varroa under laboratory test with 
fluvalinate (200 ppm)
